Our laboratory have identified the Flk-1 +CD34-CD31- hemangioblasts as the CML initiating cells and proved the rearrangement of the BCR/ABL gene might happen at the level of this hemangioblastic progenitor cells instead of HSCs20. This evidence concerns the gene PECAM1 and chronic myelogenous leukemia, BCR-ABL1 positive.